COVID-19 vaccines and kidney disease

Abstract

Patients with kidney diseases should be prioritized for COVID-19 vaccination and the available data suggest that replication-defective viral-vectored vaccines and mRNA vaccines are safe to use. As vaccine responses are likely to be lower in patients with kidney diseases than in the general population, highly potent vaccines should be preferred.

Authors

Windpessl M; Bruchfeld A; Anders H-J; Kramer H; Waldman M; Renia L; Ng LFP; Xing Z; Kronbichler A

Journal

Nature Reviews Nephrology, Vol. 17, No. 5, pp. 291–293

Publisher

Springer Nature

Publication Date

May 1, 2021

DOI

10.1038/s41581-021-00406-6

ISSN

1759-5061

Associated Experts

Zhou Xing

Professor, FHSMED

Visit profile

Labels

COVID-19 vaccines and kidney disease

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team